KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) EBT: 2009-2024

Historic EBT for Exact Sciences (EXAS) over the last 16 years, with Dec 2024 value amounting to -$1.0 billion.

  • Exact Sciences' EBT rose 52.56% to -$17.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$994.8 million, marking a year-over-year decrease of 372.42%. This contributed to the annual value of -$1.0 billion for FY2024, which is 413.60% down from last year.
  • Exact Sciences' EBT amounted to -$1.0 billion in FY2024, which was down 413.60% from -$201.7 million recorded in FY2023.
  • Exact Sciences' 5-year EBT high stood at -$201.7 million for FY2023, and its period low was -$1.0 billion during FY2024.
  • Over the past 3 years, Exact Sciences' median EBT value was -$632.6 million (recorded in 2022), while the average stood at -$623.5 million.
  • As far as peak fluctuations go, Exact Sciences' EBT spiked by 68.11% in 2023, and later plummeted by 413.60% in 2024.
  • Over the past 5 years, Exact Sciences' EBT (Yearly) stood at -$829.1 million in 2020, then dropped by 1.62% to -$842.5 million in 2021, then grew by 24.92% to -$632.6 million in 2022, then soared by 68.11% to -$201.7 million in 2023, then plummeted by 413.60% to -$1.0 billion in 2024.